The Relationship between the Triglyceride-Glucose Index and Vitamin D Levels in American Adults

Ishwarlal Jialal; Beverley Adams-Huet

doi:10.53941/ijctm.2025.100004

Abstract

The triglyceride-glucose (TyG) index is a cost-effective, reliable and validated measure of insulin resistance. Furthermore it is a promising biomarker of Metabolic Syndrome (MetS), Type-2 Diabetes (T2DM) and premature atherosclerotic cardiovascular diseases (ASCVD). Although groups from numerous countries especially Asia have shown an inverse relationship between Vitamin D levels and the TyG index, there is a severe paucity of data by US investigators. Accordingly, in the present preliminary report we investigated the relationship between tertiles of TyG index and Vitamin D levels and also undertook correlations with relevant variables. The TyG index increased significantly over tertiles in the combined group of MetS (n = 41) and controls (n = 37). However there was no significant change in plasma Vitamin D levels over tertiles, p = 0.15. We show a modest but significant correlation between TyG and Vitamin D. In conclusion in this pilot study we failed to see a significant decrease in Vitamin D levels over increasing tertiles of the TyG index but showed a modest inverse correlation. Hence future studies with much larger sample sizes of American participants can settle this important issue.

References

1.
Tao, L.C.; Xu, J.N.; Wang, T.T.; et al. Triglyceride-glucose index as a marker in cardiovascular diseases: Landscape and limitations. Cardiovasc. Diabetol. 2022, 21, 68. https://doi.org/10.1186/s12933-022-01511-x.
2.
Nayak, S.S.; Kuriyakose, D.; Polisetty, L.D.; et al. Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis. Cardiovasc. Diabetol. 2024, 23, 310. https://doi.org/10.1186/s12933-024-02392-y.
3.
Adams-Huet, B.; Zubirán, R.; Remaley, A.T.; et al. The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States. J. Clin. Lipidol. 2024, 18, e518–e524. https://doi.org/10.1016/j.jacl.2024.04.130.
4.
Devaraj, S.; Jialal, G.; Cook, T.; et al. Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm. Metab. Res. 2011, 43, 72–74. https://doi.org/10.1055/s-0030-1268485.
5.
Li, Z.; Liu, S.; Li, X.; et al. The association between the triglyceride-glucose index and vitamin D status: A systematic review and meta-analysis. BMC Endocr. Disord. 2024, 24, 222. https://doi.org/10.1186/s12902-024-01743-w.
6.
Xu, H.; Han, G.; Wang, L.; et al. 25-hydroxyvitamin D levels are inversely related to metabolic syndrome risk profile in northern Chinese subjects without vitamin D supplementation. Diabetol. Metab. Syndr. 2022, 14, 23. https://doi.org/10.1186/s13098-022-00793-1.
7.
Xiang, Q.; Xu, H.; Zhan, J.; et al. Association between the triglyceride-glucose index and vitamin D status in type 2 diabetes mellitus. Nutrients 2023, 15, 639. https://doi.org/10.3390/nu15030639.
8.
Adams-Huet, B.; Jialal, I. An increasing triglyceride-glucose index is associated with a pro-inflammatory and pro-oxidant phenotype. J. Clin. Med. 2024, 13, 3941. https://doi.org/10.3390/jcm13133941.
9.
Creo, A.L.; Rosen, J.S.; Ariza, A.J.; et al. Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children. J. Pediatr. Endocrinol. Metab. 2013, 26, 97–104. https://doi.org/10.1515/jpem-2012-0244.
10.
Al-Khalidi, B.; Rotondi, M.A.; Kimball, S.M.; et al. Clinical utility of serum 25-hydroxyvitamin D in the diagnosis of insulin resistance and estimation of optimal 25-hydroxyvitamin D in U.S. adults. Diabetes Res. Clin. Pract. 2017, 134, 80–90. https://doi.org/10.1016/j.diabres.2017.09.010.

Scilight Press

Author Information

Abstract

Keywords

References

About Scilight

Journals

Publishing Policies

Contact Us